Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches

MLA

Anuraag R. Kansal, et al. “Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.” PharmacoEconomics, vol. 32, Mar. 2014, pp. 559–72. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0f9720aa777808f8db3e590a315b9f97&authtype=sso&custid=ns315887.

APA

Anuraag R. Kansal, Christopher Pelligra, Shien Guo, Luis Hernández, & Catherine Saint-Laurent Thibault. (2014). Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches. PharmacoEconomics, 32, 559–572.

Chicago

Anuraag R. Kansal, Christopher Pelligra, Shien Guo, Luis Hernández, and Catherine Saint-Laurent Thibault. 2014. “Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.” PharmacoEconomics 32 (March): 559–72. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0f9720aa777808f8db3e590a315b9f97&authtype=sso&custid=ns315887.